2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 0 | 0 | 0 | 438 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income - EUR | 0 | 0 | 0 | 438 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Expenses - EUR | 627 | 391 | 63 | 133 | 129 | 169 | 167 | 158 | 198 | 214 |
Gross Profit/Loss - EUR | -627 | -391 | -63 | 305 | -129 | -169 | -167 | -158 | -198 | -214 |
Net Profit/Loss - EUR | -627 | -391 | -63 | 292 | -129 | -169 | -167 | -158 | -198 | -214 |
Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - X-Biomax Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 4.389 | 4.429 | 4.399 | 4.671 | 4.456 | 4.201 | 4.120 | 4.072 | 4.161 | 5.147 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 4.368 | 4.426 | 4.390 | 4.220 | 4.167 | 4.119 | 4.072 | 4.012 | 4.062 | 4.091 |
Cash | 21 | 3 | 9 | 451 | 289 | 82 | 48 | 60 | 99 | 1.056 |
Shareholders Funds | -39.005 | -39.721 | -39.380 | -38.421 | -37.846 | -37.282 | -36.741 | -36.085 | -36.395 | -36.499 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 43.462 | 44.151 | 43.778 | 43.092 | 42.301 | 41.482 | 40.861 | 40.157 | 40.556 | 41.646 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "9604 - 9604" | |||||||||
CAEN Financial Year |
9604
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - X-Biomax Srl